This investigation examines colorectal cancer cell lines bearing BRAF mutations with concomitant PIK3CA mutations and compares them to BRAF mutant cell lines without PIK3CA mutations in regard to genomic characteristics such as ploidy, MSI status, and coexisting molecular alterations. Here, BRAF is linked to colorectal cancer.